Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity. (SIRES)

This study has been completed.
Carlos III Health Institute
Information provided by (Responsible Party):
Josep M Grinyo, Hospital Universitari de Bellvitge Identifier:
First received: April 19, 2010
Last updated: February 24, 2014
Last verified: February 2014